RM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced CuSCC and HNSCC

Clinical trial NCT05220748 · WITHDRAWN

Trial details

NCT number: NCT05220748
Sponsor: Rakuten Medical, Inc.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma

Start date: 2022-03-24
Primary completion: 2023-01-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.